TD-1473 for Active Ulcerative Colitis (UC)

Clinical trial NCT02818686 · COMPLETED

Trial details

NCT number: NCT02818686
Sponsor: Theravance Biopharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ulcerative Colitis, Active Moderate Ulcerative Colitis, Active Severe

Start date: 2016-10-03
Primary completion: 2018-03-29
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.